ZA852086B - S(-)-3-(3-acetyl-4-(3-tert.butylamino-2-hydroxypropoxy)-phenyl)-1,1-diethylurea,its pharmaceutically tolerated salts,production process and pharmaceutical formulations - Google Patents

S(-)-3-(3-acetyl-4-(3-tert.butylamino-2-hydroxypropoxy)-phenyl)-1,1-diethylurea,its pharmaceutically tolerated salts,production process and pharmaceutical formulations

Info

Publication number
ZA852086B
ZA852086B ZA852086A ZA852086A ZA852086B ZA 852086 B ZA852086 B ZA 852086B ZA 852086 A ZA852086 A ZA 852086A ZA 852086 A ZA852086 A ZA 852086A ZA 852086 B ZA852086 B ZA 852086B
Authority
ZA
South Africa
Prior art keywords
diethylurea
acetyl
phenyl
hydroxypropoxy
butylamino
Prior art date
Application number
ZA852086A
Inventor
Gerhard Zoelb
Richard Gratz
Karl Schloegl
Otmar Hofer
Robert Jay Gordon
Original Assignee
Chemie Linz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemie Linz Ag filed Critical Chemie Linz Ag
Publication of ZA852086B publication Critical patent/ZA852086B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Epoxy Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

1. Claims (for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE) S(-)-3-[3-acetyl-4-(3-tert.butylamino-2-hydroxypropoxy) phenyl]-1,1-diethylurea (S(-)-celiprolol) and its pharmaceutically acceptable acid addition salts. 1. Claims (for the Contracting State AT) Process for the preparation of S(-)-3-[3-acetyl-4-(3-tert.butylamino-2-hydroxypropoxy) phenyl]-1,1-diethylurea (S(-)-celiprolol) and its pharmaceutically acceptable acid addition salts, characterised in that a) the racemate of the formula see diagramm : EP0155518,P10,F1 in the form of the base is reacted with an enantiomer of a chiral resolving acid in a suitable organic solvent, the mixture of the two diastereomeric salts formed in this manner is separated by fractional crystallisation, and, after separating each diastereomeric salt which contains the laevorotatory enantiomer of the compound of the formula I in the S configuration, is reconverted into the free base or a pharmaceutically acceptable addition salt and the resolving acid is recovered, or b) S(+)-3-[3-acetyl-4-(2,3-epoxypropoxy)-phenyl]- 1,1-diethylurea of the formula see diagramm : EP0155518,P10,F2 is reacted with tertiary butylamine in the presence of water at room temperature or with gentle heating to a maximum of 40 degrees C, and then the laevorotatory enantiomer of the compound of the formula I thus obtained is converted as required into a pharmaceutically acceptable addition salt.
ZA852086A 1984-03-21 1985-03-20 S(-)-3-(3-acetyl-4-(3-tert.butylamino-2-hydroxypropoxy)-phenyl)-1,1-diethylurea,its pharmaceutically tolerated salts,production process and pharmaceutical formulations ZA852086B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843410380 DE3410380A1 (en) 1984-03-21 1984-03-21 S (-) - CELIPROLOL, THEIR PHARMACEUTICALLY COMPATIBLE SALT, METHOD FOR THE PRODUCTION THEREOF, USE IN THERAPY AND PHARMACEUTICAL PREPARATIONS

Publications (1)

Publication Number Publication Date
ZA852086B true ZA852086B (en) 1985-11-27

Family

ID=6231193

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA852086A ZA852086B (en) 1984-03-21 1985-03-20 S(-)-3-(3-acetyl-4-(3-tert.butylamino-2-hydroxypropoxy)-phenyl)-1,1-diethylurea,its pharmaceutically tolerated salts,production process and pharmaceutical formulations

Country Status (21)

Country Link
EP (1) EP0155518B1 (en)
JP (1) JPS60209557A (en)
AT (1) ATE45945T1 (en)
AU (1) AU567797B2 (en)
CA (1) CA1236116A (en)
CS (2) CS250683B2 (en)
DD (2) DD232489A1 (en)
DE (2) DE3410380A1 (en)
DK (1) DK124585A (en)
ES (1) ES8603390A1 (en)
FI (1) FI83636C (en)
GR (1) GR850496B (en)
HU (1) HU193596B (en)
IL (1) IL74383A (en)
NO (1) NO161254C (en)
PL (2) PL143883B1 (en)
PT (1) PT80135B (en)
RO (2) RO91352B (en)
SU (2) SU1333235A3 (en)
YU (2) YU45707B (en)
ZA (1) ZA852086B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3636209A1 (en) * 1986-10-24 1988-04-28 Lentia Gmbh METHOD FOR PRODUCING A BINDER-FREE TABLET-TABLE CELIPROLOL HYDROCHLORIDE GRANULATE
AT388099B (en) * 1986-11-26 1989-04-25 Chemie Holding Ag Process for the production of solid pharmaceutical forms of 3-(3-acetyl-4-(3-tert-butylamino-2- hydroxypropoxy)phenyl)-1,1-diethylurea hydrochloride
US4931557A (en) * 1988-10-17 1990-06-05 Eli Lilly And Company Method of resolving cis 3-amino-4-(2-furyl)vinyl)-1-methoxycarbonylmethyl-azetidin-2-one and di-p-toluoyl-tartaric acid salts thereof
EP0423484B1 (en) * 1989-10-16 1993-11-03 PCD-Polymere Gesellschaft m.b.H. Tablet with sustained release
DE3935736A1 (en) * 1989-10-27 1991-05-02 Chemie Linz Deutschland Pressed article for sustained pharmaceutical release - contg. poly-lactic acid and polymer of D-3-hydroxybutyric acid, providing good flow properties and easy compression
US5227526A (en) * 1992-06-16 1993-07-13 Mallinckrodt Specialty Chemicals Company Resolution of 3-dimethylamino-2-methylpropiophenone (3-DAMP)
CN101239937B (en) * 2007-02-07 2010-05-19 上海雅本化学有限公司 Method for preparing optical activity R-(-)-1-benzylcarbonyl-3-aminopyrrolidine and hydrochloride thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT334385B (en) * 1973-12-20 1976-01-10 Chemie Linz Ag PROCESS FOR THE PREPARATION OF NEW PHENOXYPROPYLAMINE DERIVATIVES AND THEIR SALTS
HU170678B (en) * 1973-12-20 1977-08-28
HU170677B (en) * 1973-12-21 1977-08-28
US4470965A (en) * 1982-10-27 1984-09-11 Usv Pharmaceutical Corporation Celiprolol for the treatment of glaucoma

Also Published As

Publication number Publication date
HU193596B (en) 1987-11-30
YU45707B (en) 1992-07-20
FI850860L (en) 1985-09-22
YU44385A (en) 1987-06-30
DD234860A1 (en) 1986-04-16
ES541424A0 (en) 1985-12-16
DD232489A1 (en) 1986-01-29
NO161254B (en) 1989-04-17
NO161254C (en) 1989-07-26
CS250683B2 (en) 1987-05-14
RO91352B (en) 1987-05-02
DE3410380A1 (en) 1985-10-10
SU1309908A3 (en) 1987-05-07
GR850496B (en) 1985-03-15
PT80135B (en) 1987-10-20
RO91352A (en) 1987-04-30
YU44485A (en) 1987-06-30
DE3572656D1 (en) 1989-10-05
ES8603390A1 (en) 1985-12-16
DK124585D0 (en) 1985-03-20
IL74383A (en) 1988-09-30
IL74383A0 (en) 1985-05-31
FI850860A0 (en) 1985-03-04
EP0155518B1 (en) 1989-08-30
NO850834L (en) 1985-09-23
FI83636B (en) 1991-04-30
HUT37392A (en) 1985-12-28
JPS60209557A (en) 1985-10-22
AU3972285A (en) 1985-09-26
AU567797B2 (en) 1987-12-03
PL143883B1 (en) 1988-03-31
DK124585A (en) 1985-09-22
EP0155518A3 (en) 1986-06-25
PL252463A1 (en) 1985-11-19
SU1333235A3 (en) 1987-08-23
YU45246B (en) 1992-05-28
RO91353B (en) 1987-05-01
CS250682B2 (en) 1987-05-14
RO91353A (en) 1987-04-30
ATE45945T1 (en) 1989-09-15
EP0155518A2 (en) 1985-09-25
PL252462A1 (en) 1985-11-19
PT80135A (en) 1985-04-01
FI83636C (en) 1991-08-12
CA1236116A (en) 1988-05-03

Similar Documents

Publication Publication Date Title
HUT42080A (en) Process for producing labdane derivatives and pharmaceutical compositions containing them
ZA852086B (en) S(-)-3-(3-acetyl-4-(3-tert.butylamino-2-hydroxypropoxy)-phenyl)-1,1-diethylurea,its pharmaceutically tolerated salts,production process and pharmaceutical formulations
FR2363554A1 (en) NEW AMINOALKYLIDENAMINO-1,4-DIHYDROPYRIDINES, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM
FR2381777A1 (en) PROCESS FOR PREPARING OXAZOLINOAZETIDINONES FROM 6-AMINOPENICILLANIC ACID AND NEW PRODUCTS THUS OBTAINED
FR2444673A1 (en) NOVEL TRIFLUOROETHYLAMINES, PROCESSES FOR OBTAINING SAME AND THEIR USE AS MEDICAMENTS
FR2385712A1 (en) PROCESS FOR PREPARING CYCLIC ESTERS OF UNDECANEDIOIC ACID
FR2390422A1 (en) NEW 1-ACYL-2-HYDROXY-1,3-DIAMINOPROPANES, THEIR PROCESS FOR OBTAINING AND THEIR APPLICATION AS MEDICINAL PRODUCTS
EP0273316A3 (en) Stereoconvergent process for preparing optically active carboxylic acids
YU226283A (en) Process for preparing new benzazepine derivatives
FR2370052A1 (en) LACTAMES USEFUL IN PARTICULAR AS MEDICINES AND THEIR PREPARATION PROCESS
DE3169365D1 (en) Indolo-naphthyridines and their use as medicaments
FI875602A (en) OPTISKT AKTIVT TETRAHYDRO-2-FURANONDERIVAT SAOSOM MIKSOBICID.
EP0134245A4 (en) Process for preparing 3-chloro-1-formyl-4-phenyl-pyrroles.
FR2432505A1 (en) NOVEL 5-IODO-3-NITRO-4-HYDROXYBENZONITRILE SALTS, THEIR PREPARATION AND COMPOSITIONS CONTAINING THE SAME
JPS5663979A (en) Novel vinyl ether derivative and its preparation
JPH03178970A (en) 2-aromatic-3-halobenzothiazepines